Exact Mass: 459.1089

4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate

C14H21NO14S (459.0683)

4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 6-sulfate

C14H21NO14S (459.0683)

Narceinone

C23H25NO9 (459.1529)

Narceinone is found in opium poppy. Narceinone is an alkaloid from unlanced dried capsules of Papaver somniferum (opium poppy). Alkaloid from unlanced dried capsules of Papaver somniferum (opium poppy). Narceinone is found in opium poppy.

1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate

C19H25NO12 (459.1377)

Trace metabolite of corn. 1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate is found in cereals and cereal products. 1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate is found in cereals and cereal products. Trace metabolite of corn.

4-Methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-glucopyranoside

C18H21NO11S (459.0835)

Analogue A

C23H23Cl2N3O3 (459.1116)

Lilly 117018

C27H25NO4S (459.1504)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists

Mivebresib

C22H19F2N3O4S (459.1064)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

SB 212305

C20H17N3O8S (459.0736)

Phosmidosine B

C15H22N7O8P (459.1267)

Azicemicin A

C23H25NO9 (459.1529)

CHEMBL3104376

C24H21ClF3N3O (459.1325)

buprestin A

C21H21N3O9 (459.1278)

6-hydroxy-galanthindole 6-O-beta-D-glucopyranoside|6-hydroxy-galanthindolyloside A

C23H25NO9 (459.1529)

haterumaimide A

C22H31Cl2NO5 (459.1579)

ADOT

C23H25NO9 (459.1529)

Lamellarin A4

C25H17NO8 (459.0954)

haterumaimides K

C22H31Cl2NO5 (459.1579)

2-Deoxydadenosine,9CI,8CI-3,5-dibenzoyl

C24H21N5O5 (459.1543)

MMV689244

C24H21N3OClF3 (459.1325)

Cys His Asn Ser

C16H25N7O7S (459.1536)

Cys His Ser Asn

C16H25N7O7S (459.1536)

Cys Asn His Ser

C16H25N7O7S (459.1536)

Cys Asn Ser His

C16H25N7O7S (459.1536)

Cys Ser His Asn

C16H25N7O7S (459.1536)

Cys Ser Asn His

C16H25N7O7S (459.1536)

Moricizine sulfone

C22H25N3O6S (459.1464)

His Cys Asn Ser

C16H25N7O7S (459.1536)

His Cys Ser Asn

C16H25N7O7S (459.1536)

His Asn Cys Ser

C16H25N7O7S (459.1536)

His Asn Ser Cys

C16H25N7O7S (459.1536)

His Ser Cys Asn

C16H25N7O7S (459.1536)

His Ser Asn Cys

C16H25N7O7S (459.1536)

Asn Cys His Ser

C16H25N7O7S (459.1536)

Asn Cys Ser His

C16H25N7O7S (459.1536)

Asn His Cys Ser

C16H25N7O7S (459.1536)

Asn His Ser Cys

C16H25N7O7S (459.1536)

Asn Ser Cys His

C16H25N7O7S (459.1536)

Asn Ser His Cys

C16H25N7O7S (459.1536)

Ser Cys His Asn

C16H25N7O7S (459.1536)

Ser Cys Asn His

C16H25N7O7S (459.1536)

Ser His Cys Asn

C16H25N7O7S (459.1536)

Ser His Asn Cys

C16H25N7O7S (459.1536)

Ser Asn Cys His

C16H25N7O7S (459.1536)

Ser Asn His Cys

C16H25N7O7S (459.1536)

Phe-Trp-OH

C25H21N3O6 (459.143)

1-(2-Hydroxyphenylamino)-1-deoxy-b-D-gentiobioside 1,2-carbamate

C19H25NO12 (459.1377)

Narceinone

C23H25NO9 (459.1529)

5-Methyl-7-[3-(trifluoromethyl)phenyl]-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine

C22H20F3N5O3 (459.1518)

2-Propanol,1-[(6-chloro-2-methoxy-9-acridinyl)amino]-3-(diethylamino)-, hydrochloride(1:2)

C21H28Cl3N3O2 (459.1247)

Brazergoline

C23H30BrN3O2 (459.1521)

N6,3-O-DIBENZOYL-2-DEOXYADENOSINE

C24H21N5O5 (459.1543)

FR 122047 hydrochloride

C23H26ClN3O3S (459.1383)

terbium acetylacetonate

C15H24O6Tb (459.0826)

Benzyl N-N-phenylmethoxycarbonyl-N

C18H16F3N3O6S (459.0712)

(2E,5E)-3-benzyl-2-(4-methoxy phenylimino)-5-(3-methylbenzo[d]thiazol-2(3H)-ylidene)thiazolidin-4-one

C25H21N3O2S2 (459.1075)

[4-(2,4-difluorophenyl)-2-[(4-methoxyphenyl)carbamoyl]phenyl] benzoate

C27H19F2NO4 (459.1282)

(+/-)-n,n-dimethyl-1-(2-diphenylphosphino)ferrocenylethylamine monohydrate

C26H30FeNOP (459.1414)

Flurazepam hydrochloride

C21H25Cl3FN3O (459.1047)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

AZD-3759

C22H23ClFN5O3 (459.1473)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

Aluminum triquinolin-8-olate

C27H18AlN3O3 (459.1164)

Disperse Red 220

C26H22ClN3O3 (459.135)

Nitrocycline

C21H21N3O9 (459.1278)

C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

Terramycin-X

C23H25NO9 (459.1529)

4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide

C25H21N3O2S2 (459.1075)

N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-5-oxo-6-thiazolo[3,2-a]pyrimidinecarboxamide

C19H17N5O5S2 (459.0671)

Prinomastat hydrochloride

C18H22ClN3O5S2 (459.0689)

(C8-R)-Hydantocidin 5-phosphate

C13H22N3O13P (459.089)

(C8-S)-Hydantocidin 5-phosphate

C13H22N3O13P (459.089)

Mivebresib

C22H19F2N3O4S (459.1064)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

wogonin 7-O-beta-D-glucuronate

C22H19O11- (459.0927)

The monocarboxylic acid anion that is the conjugate base of wogonin 7-O-beta-D-glucuronide.

CDP-N-methylethanolamine(1-)

C12H21N4O11P2- (459.0682)

oroxylin A 7-O-beta-D-glucuronate

C22H19O11- (459.0927)

The monocarboxylic acid anion that is the conjugate base of oroxylin A 7-O-beta-D-glucuronide.

5-O-[N-(L-Aspartyl)sulfamoyl]adenosine

C14H17N7O9S-2 (459.0808)

4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc

C14H21NO14S (459.0683)

Aspartyl-phosphonate-adenosine

C15H20N6O9P- (459.1029)

2-Acetyl-2-decarboxyamido-oxytetracycline

C23H25NO9 (459.1529)

(2R,3R,4S)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)

5-chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide

C23H23Cl2N3O3 (459.1116)

[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(methylazaniumyl)ethyl phosphate

C12H21N4O11P2- (459.0682)

4-(2,6-Difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperidine

C19H19F2NO6S2 (459.0622)

(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H19N4O5S2+ (459.0797)

[3,5-bis(difluoromethyl)-5-hydroxy-4H-pyrazol-1-yl]-[2-(4-propan-2-ylphenyl)-4-quinolinyl]methanone

C24H21F4N3O2 (459.157)

(Z)-4-(1,3-benzothiazol-2-yl)-5-[4-(N-methylanilino)-3-nitrophenyl]-4-pentenoic acid

C25H21N3O4S (459.1253)

N-{2-[4-(4-chlorobenzoyl)-1-piperazinyl]phenyl}-1-benzofuran-2-carboxamide

C26H22ClN3O3 (459.135)

3-(4-Butyl-3-oxo-2-quinoxalinyl)propanoic acid [2-(3-chloro-4-fluoroanilino)-2-oxoethyl] ester

C23H23ClFN3O4 (459.1361)

4-[(2-Methoxyphenyl)-methylsulfamoyl]benzoic acid [2-[(5-methyl-3-isoxazolyl)amino]-2-oxoethyl] ester

C21H21N3O7S (459.11)

5-chloro-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-2-benzofurancarboxamide

C21H18ClN3O5S (459.0656)

1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(2-bromophenyl)methylidene]-5-(pyrrolidin-1-ylmethyl)-1H-1,2,3-triazole-4-carbohydrazide

C17H18BrN9O2 (459.0767)

prunetin-5-O-beta-D-glucuronide

C22H19O11- (459.0927)

prunetin-4-O-beta-D-glucuronide

C22H19O11- (459.0927)

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc6S

C14H21NO14S (459.0683)

(6R,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

Farnesyl triphosphate(3-)

C15H26O10P3-3 (459.0739)

2-(Acetylamino)-2-Deoxy-3-O-(4-Deoxy-Alpha-L-Threo-Hex-4-Enopyranuronosyl)-4-O-Sulfo-Beta-D-Galactopyranose

C14H21NO14S (459.0683)

(5-fluoro-2,4-dioxo-1H-pyrimidin-6-yl) 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylate

C21H19F2N5O5 (459.1354)

(S)-2-(4-Chlorophenyl)-2-Pyridin-3-Yl-1-[4-[4-(Trifluoromethyl)phenyl]piperazin-1-Yl]ethanone

C24H21ClF3N3O (459.1325)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-4-O-sulfo-D-galactopyranose

C14H21NO14S (459.0683)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-6-O-sulfo-D-galactopyranose

C14H21NO14S (459.0683)

Lilly 117018

C27H25NO4S (459.1504)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists

1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate

C19H25NO12 (459.1377)

ST 18:3;O6;Tau

C20H29NO9S (459.1563)

KG5

C20H16F3N7OS (459.1089)

KG5 is an orally active dual PDGFRβ and B-Raf allosteric inhibitor. KG5 also inhibits Flt3, KIT and c-Raf. KG5 has anticancer, antiangiogenic activities[1].

(4r,5s,6r)-4,5-dihydroxy-6-[(s)-[(3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

C17H21N3O12 (459.1125)

12-(3,4-dihydroxyphenyl)-7,8,16,17-tetrahydroxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-5,7,9,12,14,16,18,20-octaen-3-one

C25H17NO8 (459.0954)

(4s,5s,6s)-4,5-dihydroxy-6-[(r)-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

C17H21N3O12 (459.1125)

1-(2-hydroxyphenylamino)-1-deoxy-β-gentio-bioside 1,2-carbamate

C19H25NO12 (459.1377)

{"Ingredient_id": "HBIN000886","Ingredient_name": "1-(2-hydroxyphenylamino)-1-deoxy-\u03b2-gentio-bioside 1,2-carbamate","Alias": "NA","Ingredient_formula": "C19H25NO12","Ingredient_Smile": "C1=CC=C(C(=C1)N2C3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)OC2=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10608","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(3r,4ar,12bs)-3,7,8,10,12b-pentahydroxy-9,12-dimethoxy-3-[(1r,2r)-1-methylaziridin-2-yl]-2,4,4a,5-tetrahydrotetraphene-1,6-dione

C23H25NO9 (459.1529)

8-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C20H17N3O8S (459.0736)

4,11,24,25-tetrahydroxy-25-(1-hydroxyethyl)-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2(15),3,5(14),7,9,11,18,20,22-nonaene-6,13-dione

C26H21NO7 (459.1318)

8-{[(2s)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C20H17N3O8S (459.0736)

(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-(1h-pyrrole-2-carbonyloxy)-6-[(1h-pyrrole-2-carbonyloxy)methyl]oxan-2-yl 1h-pyrrole-2-carboxylate

C21H21N3O9 (459.1278)

(1r,17s,24s,25r)-4,11,24,25-tetrahydroxy-25-[(1r)-1-hydroxyethyl]-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2(15),3,5(14),7,9,11,18,20,22-nonaene-6,13-dione

C26H21NO7 (459.1318)

(2r,3s,5s,6s)-6-{[(3s,3ar)-7-chloro-5-(cyanomethyl)-3-hydroxy-3h-cyclopenta[a]inden-3a-yl]oxy}-5-hydroxy-2,3-dimethyl-4-oxooxan-3-yl acetate

C23H22ClNO7 (459.1085)

(2s)-n-{[(2r,3s,4r,5r)-5-(6-amino-8-hydroxypurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}pyrrolidine-2-carboximidic acid

C15H22N7O8P (459.1267)

3,7,8,10,12b-pentahydroxy-9,12-dimethoxy-3-(1-methylaziridin-2-yl)-2,4,4a,5-tetrahydrotetraphene-1,6-dione

C23H25NO9 (459.1529)

3-acetyl-1-(dimethylamino)-4,4a,6,7,11,12-hexahydroxy-11-methyl-1,11a,12,12a-tetrahydrotetracene-2,5-dione

C23H25NO9 (459.1529)

(3r,4ar,12bs)-3,7,8,10,12b-pentahydroxy-9,12-dimethoxy-3-[(2r)-1-methylaziridin-2-yl]-2,4,4a,5-tetrahydrotetraphene-1,6-dione

C23H25NO9 (459.1529)